S&P 500
7,757.17
+44.60
+0.58%
Dow
52,856.10
+360.20
+0.69%
Nasdaq
26,702.86
+278.04
+1.05%
NYSE Composite
24,253.12
+62.52
+0.26%
Russell 2000
2,781.02
+7.60
+0.27%
VIX
18.46
+1.78
+10.67%
PAHC · Phibro Animal Health Corporation Class A
NASDAQ NMS - GLOBAL MARKET - Real Time Price • USD
Phibro Animal Health Corp (PAHC)
NASDAQ NMS - GLOBAL MARKET
Pharmaceuticals
$39.25
+0.40
(+1.02%)
● At close: October 21 at 4:00:00 PM EDT
DAY'S RANGE
$39.25
$38.58
$39.30
52-WEEK RANGE
$39.25
$28.25
$60.08
What's happening
- PAHC is up 1.02% today, trading at $39.25. — Live quote
- Volume today (14,468) is well below its 3-month average of 244,150. (Finnhub fundamentals)
- Reports earnings on 2026-11-11, 20 days away. (Finnhub earnings calendar)
- Last quarter's EPS beat estimates: $0.85 actual vs. $0.73 estimated (+16.9%). (Finnhub earnings history)
Deterministic template sentences filled in from the same sourced figures shown elsewhere on this page -- not an AI-written summary, no live model call.
Key Statistics
Analyst Recommendations
Strong buy 0
Buy 1
Hold 4
Sell 2
Strong sell 2
Aggregate ratings for 2026-10-01 (9 analysts polled by Finnhub) — consensus count.
Performance Overview (Trailing returns vs S&P 500 benchmark)
YTD RETURN
PAHC
+3.85%
vs S&P 500
-8.92%
1-YEAR RETURN
PAHC
-4.48%
vs S&P 500
-19.04%
6-MONTH RETURN
PAHC
-27.99%
3-MONTH RETURN
PAHC
+14.59%
Earnings Trends (Quarterly EPS Actual vs Estimate)
2026-07-26 (Q4 2026)
$0.85
Est. $0.73
BEAT +16.9%
2026-04-26 (Q3 2026)
$0.76
Est. $0.73
BEAT +4.5%
2026-01-26 (Q2 2026)
$0.87
Est. $0.68
BEAT +27.3%
2025-10-26 (Q1 2026)
$0.73
Est. $0.64
BEAT +15.0%
Valuation Measures & Ratios
Enterprise Value4$2.25B
Forward P/E59.86
PEG Ratio61.46
Price / Sales (TTM1)1.04
Price / Book73.30
EV4 / Revenue1.48
EV4 / EBITDA9.14
Profit Margin6.57%
Operating Margin12.81%
Return on Equity (ROE8)28.67%
Return on Assets (ROA9)6.95%
Avg Volume (3M)244,150
Quarterly history (5 periods)
| Measure | Mar '26 | Dec '25 | Sep '25 | Mar '25 | Dec '24 |
|---|---|---|---|---|---|
| Market cap | $2.23B | $1.52B | $1.63B | $856.5M | $813.0M |
| P/E | 22.60 | 19.43 | 28.34 | 21.71 | 40.98 |
| Price/Sales | 1.52 | 1.09 | 1.27 | 0.73 | 0.75 |
| Price/Book | 6.18 | 4.56 | 5.23 | 3.22 | 3.29 |
| EV/Revenue | 1.91 | 1.50 | 1.71 | 1.21 | 1.28 |
| EV/EBITDA | 12.15 | 9.91 | 12.57 | — | — |
| ROE | 27.33% | 23.48% | 18.47% | 14.83% | 8.04% |
| ROA | 6.84% | 5.55% | 4.15% | 2.99% | 1.54% |
Trailing-twelve-month ratios computed from SEC EDGAR quarterly figures and historical daily close prices (Alpaca). Diluted shares are derived from Net income ÷ EPS (diluted) for each quarter, not separately reported. Forward P/E/PEG unavailable (no free data source).
Glossary — what these abbreviations mean
- 1. TTM
- Trailing twelve months — the sum of the last four reported quarters, not a calendar year or the single latest quarter.
- 2. EPS
- Earnings per share — net income divided by diluted shares outstanding.
- 3. Beta
- A stock's historical volatility relative to the overall market. Above 1 means it has moved more than the market; below 1, less.
- 4. EV (Enterprise Value)
- Market cap plus total debt minus cash — roughly what it would cost to buy the whole company, debt included.
- 5. Forward P/E
- Price divided by analysts' estimated earnings for the next 12 months, instead of trailing actual earnings.
- 6. PEG Ratio
- P/E divided by expected earnings growth rate. A lower number can indicate a stock is cheap relative to how fast it's expected to grow.
- 7. Price / Book
- Share price divided by book value (assets minus liabilities) per share.
- 8. ROE
- Return on equity — net income divided by shareholders' equity, a measure of how efficiently a company turns equity into profit.
- 9. ROA
- Return on assets — net income divided by total assets, a measure of how efficiently a company turns assets into profit.
- 10. MRQ
- Most recent quarter — the single latest reported period, as opposed to TTM. The Financials section's "Quarterly" view below shows MRQ-style figures.
- 11. YoY
- Year over year — percent change versus the same period one year earlier, used for growth figures like those on Compare cards and the Screener.
Short Interest
Shares Short1,020,961
Change from Prior Settlement-10.62%
% of Float—
Days to Cover (Short Ratio)4.06
Source: FINRA Rule 4560 consolidated short interest, settlement date 2026-09-30. Reported bi-monthly with a reporting lag — not real-time.
Quotes and the 1-day extended-hours chart: Yahoo Finance. Longer historical charts: Alpaca (IEX feed) — real-time but IEX-only volume (~2.5% of consolidated market volume). Fundamentals + earnings: Finnhub.
Price history
Events
Drag horizontally to zoom into a section; use Reset view to restore all observations.
Technical signal summary
Calculating from the latest year of daily price history…
Show Technical Analysis Breakdown ▾ 10 Indicators
Not investment advice — read several signals together.
Indicators None active
Loading chart…
History limited by data provider; markers are heuristics, not signals.
Peer and sector context
No reviewed peer group is available for this symbol.
Balanced evidence
A deterministic summary of sourced facts—not an AI verdict.
Potential strengths
- Revenue growth is 4.8% on the provider's reported measure. Finnhub fundamentals ↗
- Latest SEC filing is Form 8-K, filed 2026-08-26; review it for current changes and risks. SEC EDGAR ↗
Potential concerns
- Net profit margin is 6.6%. Finnhub fundamentals ↗
- Trailing 52-week price return is -4.5%. Finnhub market metrics ↗
Rule-based facts only; absence from either side is not evidence, and this is not a recommendation.
More on PAHC
No accessible free API for these — links go to the source directly.
Financials
Fundamental trends
Visualized from the same SEC figures in the tables below.
Income statement
| Line item | Mar '26 | Dec '25 | Sep '25 | Mar '25 | Dec '24 | Sep '24 | Mar '24 | Dec '23 |
|---|---|---|---|---|---|---|---|---|
| Revenue | $383.5M | $373.9M | $363.9M | $347.8M | $309.3M | $260.4M | $263.2M | $249.9M |
| Gross profit | $125.7M | $132.7M | $119.8M | $104.6M | $101.9M | $83.5M | $79.6M | $78.6M |
| Operating income | $44.7M | $50.3M | $51.3M | $33.5M | $25.5M | $17.7M | $19.9M | $15.7M |
| Net income | $24.0M | $27.5M | $26.5M | $20.9M | $3.2M | $7.0M | $8.4M | $1.3M |
| EPS (diluted) | $0.59 | $0.67 | $0.65 | $0.51 | $0.08 | $0.17 | $0.21 | $0.03 |
| EPS (basic) | $0.59 | $0.68 | $0.65 | $0.52 | $0.08 | $0.17 | $0.21 | $0.03 |
| Operating margin | $12 | $13 | $14 | $10 | $8 | $7 | $8 | $6 |
| Net margin | $6 | $7 | $7 | $6 | $1 | $3 | $3 | $1 |
Balance sheet
| Line item | Jun '26 | Mar '26 | Dec '25 | Sep '25 | Jun '25 | Mar '25 | Dec '24 | Sep '24 |
|---|---|---|---|---|---|---|---|---|
| Total assets | $1.50B | $1.45B | $1.41B | $1.39B | $1.36B | $1.32B | $1.29B | $966.3M |
| Total liabilities | $1.12B | $1.08B | $1.07B | $1.07B | $1.08B | $1.05B | $1.04B | $707.8M |
| Stockholders' equity | $385.5M | $361.8M | $332.4M | $311.7M | $285.7M | $266.0M | $246.8M | $258.5M |
| Total current assets | $935.5M | $894.1M | $862.2M | $835.8M | $810.6M | $776.0M | $746.2M | $570.8M |
| Total current liabilities | $316.5M | $281.9M | $282.4M | $270.1M | $293.5M | $266.5M | $233.2M | $176.9M |
| Cash & equivalents | $61.4M | $54.9M | $55.5M | $72.8M | $68.0M | $60.4M | $67.1M | $51.8M |
| Marketable securities (current) | $20.6M | $22.5M | $19.0M | $12.5M | $9.0M | $10.0M | $0 | $38.0M |
| Accounts receivable | $238.8M | $221.5M | $215.9M | $217.9M | $228.0M | $197.5M | $191.8M | $160.8M |
| Inventory | $534.9M | $539.7M | $517.3M | $471.8M | $444.4M | $448.4M | $427.2M | $272.6M |
| Other current assets | $79.8M | $55.4M | $54.5M | $60.9M | $61.2M | $59.8M | $60.1M | $47.6M |
| Property, plant & equipment | $369.2M | $359.3M | $355.4M | $354.8M | $354.7M | $336.1M | $337.7M | $206.3M |
| Goodwill | $60.0M | $59.9M | $59.8M | $59.7M | $59.6M | $54.6M | $54.5M | $54.6M |
| Intangible assets | $30.1M | $31.7M | $33.1M | $35.0M | $36.5M | $37.8M | $39.9M | $42.9M |
| Other non-current assets | $106.5M | $100.2M | $95.1M | $100.3M | $99.5M | $112.8M | $107.3M | $91.7M |
| Accounts payable | $127.3M | $129.6M | $133.3M | $130.6M | $138.2M | $131.6M | $99.4M | $86.5M |
| Accrued liabilities | — | — | — | — | — | — | — | — |
| Deferred revenue (current) | — | — | — | — | — | — | — | — |
| Short-term debt | — | $22.8M | $20.6M | $18.4M | $16.2M | $16.2M | $16.2M | $7.5M |
| Other current liabilities | $29.9M | $29.9M | $29.1M | $29.5M | $31.2M | $41.7M | $46.8M | $18.2M |
| Long-term debt | — | $597.7M | $603.6M | $609.5M | $615.4M | $619.2M | $622.9M | $287.7M |
| Other non-current liabilities | $91.5M | $88.7M | $80.2M | $79.2M | $79.3M | $73.6M | $68.6M | $64.2M |
| Retained earnings | $353.0M | $336.1M | $317.0M | $294.4M | $272.7M | $260.3M | $244.3M | $246.0M |
| Accumulated other comprehensive income (loss) | -$106.1M | -$112.5M | -$122.4M | -$120.0M | -$124.0M | -$131.2M | -$134.2M | -$123.9M |
Cash flow
| Line item | Jun '26 | Mar '26 | Dec '25 | Sep '25 | Jun '25 | Mar '25 | Dec '24 | Sep '24 |
|---|---|---|---|---|---|---|---|---|
| Operating cash flow | $24.1M | $16.2M | $19.4M | $9.3M | $21.3M | $43.2M | $3.1M | $12.6M |
| Investing cash flow | -$16.5M | -$16.8M | -$17.2M | -$21.0M | -$7.0M | -$18.3M | -$260.5M | -$2.9M |
| Financing cash flow | -$1.6M | -$2.3M | -$19.0M | $16.3M | -$7.8M | -$32.2M | $276.3M | -$29.2M |
| Depreciation & amortization | $38.7M | $12.4M | $12.9M | $12.8M | $36.6M | $12.6M | $11.6M | $9.0M |
| Share-based compensation | $413.0K | $411.0K | $434.0K | $339.0K | $179.0K | $179.0K | $180.0K | $179.0K |
| Deferred income taxes | $7.2M | — | — | — | -$4.8M | — | — | — |
| Change in accounts receivable | $16.4M | $4.8M | -$2.3M | -$11.4M | $26.0M | $3.5M | $35.0M | -$9.2M |
| Change in inventory | -$6.2M | $19.3M | $47.0M | $26.2M | $6.2M | $13.7M | $19.2M | $5.2M |
| Change in accounts payable | -$5.6M | -$2.9M | $753.0K | -$4.6M | $2.6M | $28.3M | $13.3M | $1.3M |
| Other investing activities | -$471.0K | -$2.0M | -$431.0K | $3.7M | $241.0K | -$548.0K | -$174.0K | -$653.0K |
| Dividends paid | — | — | — | — | — | — | — | — |
| Debt issued | — | — | — | — | — | — | — | — |
Income statement
| Line item | Jun '26 | Jun '25 | Jun '24 | Jun '23 | Jun '22 |
|---|---|---|---|---|---|
| Revenue | $1.52B | $1.30B | $1.02B | $977.9M | $942.3M |
| Gross profit | $512.5M | $399.9M | $313.1M | $298.2M | $285.4M |
| Operating income | $194.4M | $110.5M | $53.3M | $71.8M | $79.0M |
| Net income | $99.7M | $48.3M | $2.4M | $32.6M | $49.2M |
| EPS (diluted) | $2.43 | $1.19 | $0.06 | $0.81 | $1.21 |
| EPS (basic) | $2.46 | $1.19 | $0.06 | $0.81 | $1.21 |
| Operating margin | $13 | $9 | $5 | $7 | $8 |
| Net margin | $7 | $4 | $0 | $3 | $5 |
Balance sheet
| Line item | Jun '26 | Jun '25 | Jun '24 | Jun '23 | Jun '22 |
|---|---|---|---|---|---|
| Total assets | $1.50B | $1.36B | $982.2M | $971.4M | $931.7M |
| Total liabilities | $1.12B | $1.08B | $725.5M | $688.9M | $669.3M |
| Stockholders' equity | $385.5M | $285.7M | $256.6M | $282.5M | $262.4M |
| Total current assets | $935.5M | $810.6M | $601.0M | $585.7M | $566.2M |
| Total current liabilities | $316.5M | $293.5M | $204.1M | $176.0M | $190.8M |
| Cash & equivalents | $61.4M | $68.0M | $70.6M | $41.3M | $74.2M |
| Marketable securities (current) | $20.6M | $9.0M | $44.0M | $40.0M | $17.0M |
| Accounts receivable | $238.8M | $228.0M | $169.5M | $163.5M | $166.5M |
| Inventory | $534.9M | $444.4M | $265.9M | $277.6M | $259.2M |
| Other current assets | $79.8M | $61.2M | $51.0M | $63.4M | $49.3M |
| Property, plant & equipment | $369.2M | $354.7M | $203.3M | $195.6M | $165.5M |
| Goodwill | $60.0M | $59.6M | $54.6M | $53.3M | $53.2M |
| Intangible assets | $30.1M | $36.5M | $45.0M | $55.0M | $63.9M |
| Other non-current assets | $106.5M | $99.5M | $78.3M | $81.8M | $82.9M |
| Accounts payable | $127.3M | $138.2M | $85.6M | $73.9M | $95.6M |
| Accrued liabilities | — | — | — | — | — |
| Deferred revenue (current) | — | — | — | $370.0K | $822.0K |
| Short-term debt | — | — | $29.8M | $22.3M | $15.0M |
| Other current liabilities | $29.9M | $31.2M | $17.5M | $18.9M | $18.9M |
| Long-term debt | — | — | $282.3M | $311.5M | $272.9M |
| Other non-current liabilities | $91.5M | $79.3M | $63.1M | $60.3M | $60.5M |
| Retained earnings | $353.0M | $272.7M | $243.9M | $260.9M | $247.7M |
| Accumulated other comprehensive income (loss) | -$106.1M | -$124.0M | -$123.5M | -$114.2M | -$121.1M |
Cash flow
| Line item | Jun '26 | Jun '25 | Jun '24 | Jun '23 | Jun '22 |
|---|---|---|---|---|---|
| Operating cash flow | $69.0M | $80.1M | $87.6M | $13.3M | $31.6M |
| Investing cash flow | -$71.5M | -$288.7M | -$48.2M | -$74.0M | -$22.6M |
| Financing cash flow | -$6.6M | $207.1M | -$6.8M | $27.0M | $16.3M |
| Depreciation & amortization | $51.5M | $45.6M | $36.2M | $34.0M | $32.7M |
| Share-based compensation | $1.6M | $717.0K | $475.0K | — | — |
| Deferred income taxes | $7.2M | -$4.8M | -$12.0M | -$2.9M | -$803.0K |
| Change in accounts receivable | $7.5M | $55.2M | $8.7M | -$5.3M | $23.6M |
| Change in inventory | $86.3M | $44.3M | -$2.6M | $11.2M | $47.0M |
| Change in accounts payable | -$12.5M | $45.6M | $12.0M | -$22.8M | $26.4M |
| Other investing activities | $792.0K | -$1.1M | -$326.0K | -$776.0K | -$620.0K |
| Dividends paid | — | — | — | — | — |
| Debt issued | — | — | — | — | — |
Source: SEC EDGAR XBRL filings (10-Q/10-K), as originally tagged by the company. Quarterly cash flow is reconstructed by de-cumulating fiscal-year-to-date figures (how cash flow is tagged in 10-Qs); other quarterly lines are reported directly.
Institutional holders
SEC Form 13F filers holding PAHC as of the latest reported quarter. 13F only covers investment managers with $100M+ in assets — this is not a complete ownership picture, and does not include insiders (see Recent SEC filings below) or non-13F-eligible holders.
Institutional ownership is not available for this symbol right now.
Insider activity
Directors, officers, and 10%+ owners' reported transactions from SEC Form 4. A filing reports a transaction; it does not by itself explain why it happened.
Source: SEC EDGAR Form 4 filings · checked 25 most recent filings · covers 2026-02-24 to 2026-08-06
Recent transactions
- Insiders have net sold 36,768 shares over the last 182 days, across 1 purchase and 16 sales.
- Most recent: Rodriguez Patrick (VP Finance and Treasurer) — Grant / award of 1,503 shares on 2026-08-06.
Deterministic template sentences filled in from the SEC Form 4 figures in the tables below -- not an AI-written summary, no live model call.
Insider purchases & sales, last 6 months
Purchases (open market)10,000 sh(1 txns)
Sales (open market)46,768 sh(16 txns)
Net Shares-36,768
Counts only open-market purchases (code P) and sales (code S) — grants, option exercises, tax withholding, and gifts are excluded since they aren't a market buy/sell decision.
Insider roster
| Name | Title | Most Recent Transaction | Date | Shares |
|---|---|---|---|---|
| Rodriguez Patrick | VP Finance and Treasurer | Grant / award | 2026-08-06 | 1,503 |
| David Glenn | Chief Financial Officer | Grant / award | 2026-08-06 | 3,334 |
| Miller Larry Lee | Chief Operating Officer | Grant / award | 2026-08-06 | 3,522 |
| BENDHEIM Jonathan | Director | Grant / award | 2026-08-06 | 2,716 |
| Weinstein Judith | See Remarks | Grant / award | 2026-08-06 | 2,478 |
| BENDHEIM JACK | Executive Chairman | Grant / award | 2026-08-06 | 12,103 |
| Escudero Lisa Ann | See Remarks | Grant / award | 2026-08-06 | 1,547 |
| Bendheim Daniel M | President and CEO | Grant / award | 2026-08-06 | 11,699 |
| CORCORAN E THOMAS | Director | Open market purchase | 2026-05-29 | 10,000 |
Recent transactions
| Date | Insider | Title | Transaction | Shares | Price |
|---|---|---|---|---|---|
| 2026-08-06 | Rodriguez Patrick | VP Finance and Treasurer | Grant / award | 1,503 | $0.00 |
| 2026-08-06 | David Glenn | Chief Financial Officer | Grant / award | 3,334 | $0.00 |
| 2026-08-06 | Miller Larry Lee | Chief Operating Officer | Grant / award | 3,522 | $0.00 |
| 2026-08-06 | BENDHEIM Jonathan | Director | Grant / award | 2,716 | $0.00 |
| 2026-08-06 | Weinstein Judith | See Remarks | Grant / award | 2,478 | $0.00 |
| 2026-08-06 | BENDHEIM JACK | Executive Chairman | Grant / award | 12,103 | $0.00 |
| 2026-08-06 | Escudero Lisa Ann | See Remarks | Grant / award | 1,547 | $0.00 |
| 2026-08-06 | Bendheim Daniel M | President and CEO | Grant / award | 11,699 | $0.00 |
| 2026-08-04 | BENDHEIM JACK | Executive Chairman | Other acquisition/disposition | 2,303 | $36.60 |
| 2026-08-04 | Escudero Lisa Ann | See Remarks | Other acquisition/disposition | 265 | $36.60 |
| 2026-08-04 | Miller Larry Lee | Chief Operating Officer | Other acquisition/disposition | 635 | $36.60 |
| 2026-08-04 | Weinstein Judith | See Remarks | Other acquisition/disposition | 472 | $36.60 |
| 2026-08-04 | David Glenn | Chief Financial Officer | Other acquisition/disposition | 840 | $36.60 |
| 2026-08-04 | Bendheim Daniel M | President and CEO | Other acquisition/disposition | 486 | $36.60 |
| 2026-05-29 | CORCORAN E THOMAS | Director | Open market purchase | 10,000 | $31.77 |
| 2026-05-07 | BENDHEIM JACK | President and CEO | Open market sale | 1,350 | $47.59 |
| 2026-05-07 | BENDHEIM JACK | President and CEO | Open market sale | 1,149 | $48.31 |
| 2026-05-07 | BENDHEIM JACK | President and CEO | Open market sale | 2,029 | $49.19 |
| 2026-05-06 | BENDHEIM JACK | President and CEO | Open market sale | 5,634 | $57.18 |
| 2026-05-06 | BENDHEIM JACK | President and CEO | Open market sale | 1,406 | $58.13 |
| 2026-05-05 | BENDHEIM JACK | President and CEO | Open market sale | 6,264 | $55.73 |
| 2026-05-05 | BENDHEIM JACK | President and CEO | Open market sale | 776 | $56.37 |
| 2026-04-30 | BENDHEIM JACK | President and CEO | Open market sale | 5,805 | $52.65 |
| 2026-04-30 | BENDHEIM JACK | President and CEO | Open market sale | 1,235 | $53.32 |
| 2026-04-29 | BENDHEIM JACK | President and CEO | Open market sale | 4,002 | $52.70 |
| 2026-04-29 | BENDHEIM JACK | President and CEO | Open market sale | 3,038 | $53.21 |
| 2026-04-28 | BENDHEIM JACK | President and CEO | Open market sale | 1,652 | $55.10 |
| 2026-04-28 | BENDHEIM JACK | President and CEO | Open market sale | 4,591 | $56.06 |
| 2026-04-28 | BENDHEIM JACK | President and CEO | Open market sale | 797 | $56.69 |
| 2026-04-23 | BENDHEIM JACK | President and CEO | Open market sale | 6,619 | $54.07 |
| 2026-04-23 | BENDHEIM JACK | President and CEO | Open market sale | 421 | $54.56 |
| 2026-04-22 | BENDHEIM JACK | President and CEO | Open market sale | 7,040 | $54.29 |
| 2026-04-21 | BENDHEIM JACK | President and CEO | Open market sale | 1,625 | $55.35 |
| 2026-04-21 | BENDHEIM JACK | President and CEO | Open market sale | 5,415 | $56.17 |
| 2026-04-16 | BENDHEIM JACK | President and CEO | Derivative conversion | 100,000 | $0.00 |
| 2026-04-16 | BENDHEIM JACK | President and CEO | Open market sale | 5,190 | $54.56 |
| 2026-04-16 | BENDHEIM JACK | President and CEO | Open market sale | 1,850 | $54.88 |
| 2026-04-15 | BENDHEIM JACK | President and CEO | Open market sale | 2,623 | $56.27 |
| 2026-04-15 | BENDHEIM JACK | President and CEO | Open market sale | 3,618 | $57.21 |
| 2026-04-15 | BENDHEIM JACK | President and CEO | Open market sale | 799 | $58.11 |
| 2026-04-14 | BENDHEIM JACK | President and CEO | Open market sale | 6,548 | $59.03 |
| 2026-04-14 | BENDHEIM JACK | President and CEO | Open market sale | 492 | $59.69 |
| 2026-03-31 | BENDHEIM JACK | President and CEO | Open market sale | 6,609 | $53.87 |
| 2026-03-31 | BENDHEIM JACK | President and CEO | Open market sale | 431 | $54.35 |
| 2026-03-30 | BENDHEIM JACK | President and CEO | Open market sale | 6,423 | $53.54 |
| 2026-03-30 | BENDHEIM JACK | President and CEO | Open market sale | 617 | $54.31 |
| 2026-03-26 | BENDHEIM JACK | President and CEO | Open market sale | 6,760 | $56.79 |
| 2026-03-26 | BENDHEIM JACK | President and CEO | Open market sale | 280 | $57.17 |
| 2026-03-25 | BENDHEIM JACK | President and CEO | Open market sale | 1,572 | $55.28 |
| 2026-03-25 | BENDHEIM JACK | President and CEO | Open market sale | 4,916 | $56.00 |
| 2026-03-25 | BENDHEIM JACK | President and CEO | Open market sale | 552 | $56.86 |
| 2026-03-24 | BENDHEIM JACK | President and CEO | Open market sale | 6,523 | $52.88 |
| 2026-03-24 | BENDHEIM JACK | President and CEO | Open market sale | 517 | $53.59 |
| 2026-03-19 | BENDHEIM JACK | President and CEO | Open market sale | 1,939 | $51.78 |
| 2026-03-19 | BENDHEIM JACK | President and CEO | Open market sale | 4,977 | $52.79 |
| 2026-03-19 | BENDHEIM JACK | President and CEO | Open market sale | 124 | $53.24 |
| 2026-03-18 | BENDHEIM JACK | President and CEO | Open market sale | 4,311 | $51.80 |
| 2026-03-18 | BENDHEIM JACK | President and CEO | Open market sale | 3,598 | $53.03 |
| 2026-03-18 | BENDHEIM JACK | President and CEO | Open market sale | 2,651 | $53.64 |
| 2026-03-17 | BENDHEIM JACK | President and CEO | Open market sale | 5,280 | $51.66 |
Showing the most recent 60 transactions.
Recent SEC filings
Official company reports and insider transaction filings. Form 4 reports a transaction; it does not by itself explain why it happened.
Source: SEC EDGAR submissions · updated 2026-10-22 08:20 UTC
| Filed | Form | Report period | Official filing |
|---|---|---|---|
| 2026-08-26 | 8-K | 2026-08-26 | View on SEC.gov → |
| 2026-08-26 | 10-K | 2026-06-30 | View on SEC.gov → |
| 2026-08-10 | 4 | 2026-08-06 | View on SEC.gov → |
| 2026-08-10 | 4 | 2026-08-06 | View on SEC.gov → |
| 2026-08-10 | 4 | 2026-08-06 | View on SEC.gov → |
| 2026-08-10 | 4 | 2026-08-06 | View on SEC.gov → |
| 2026-08-10 | 4 | 2026-08-06 | View on SEC.gov → |
| 2026-08-10 | 4 | 2026-08-06 | View on SEC.gov → |
| 2026-08-10 | 4 | 2026-08-06 | View on SEC.gov → |
| 2026-08-10 | 4 | 2026-08-06 | View on SEC.gov → |
| 2026-08-06 | 4 | 2026-08-04 | View on SEC.gov → |
| 2026-08-06 | 4 | 2026-08-04 | View on SEC.gov → |
Recent news
Headlines about PAHC (Phibro Animal Health Corporation Class A). Links open the publisher — we don’t host full articles.
-
How Unusual Is Zoetis's Latest Sales Growth?
Yahoo Finance · 2026-10-22 -
PAHC or SYK: Which Is the Better Value Stock Right Now?
Yahoo · 2026-10-21 -
ELV Beats Q3 Earnings Estimates on Carelon Strength, Raises 2026 Outlook
Yahoo · 2026-10-21 -
Can Higher Admissions Offset Rising Costs in UHS' Q3 Earnings?
Yahoo · 2026-10-21 -
ABT Stock Down Post Q3 Earnings Miss, Revenues Rise Y/Y, Margins Up
Yahoo · 2026-10-21 -
BSX Set to Report Q3 Earnings: Will MedSurg Strength Aid Performance?
Yahoo · 2026-10-21 -
Ecolab Gears Up to Report Q3 Results: How to Play the Stock?
Yahoo · 2026-10-21 -
Three reporting persons share voting power over 822,639 Phibro Animal Health (PAHC) shares.
Stock Titan · 2026-10-19
No headlines in this category right now — try “All”.